Jens D Lundgren Selected Research

Jens D Lundgren Research Topics

Disease

37	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 01/2002
30	Infections 01/2022 - 07/2002
21	HIV Infections (HIV Infection) 08/2016 - 08/2002
19	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2003
14	Neoplasms (Cancer) 01/2021 - 06/2004
14	Inflammation (Inflammations) 10/2020 - 05/2002
11	Disease Progression 01/2021 - 01/2002
11	Coinfection 12/2020 - 03/2005
10	Myocardial Infarction 01/2018 - 11/2003
9	COVID-19 01/2022 - 10/2020
8	Critical Illness (Critically Ill) 01/2019 - 07/2008
8	Hepatitis B 07/2014 - 03/2005
6	Diabetes Mellitus 12/2020 - 05/2003
6	Sepsis (Septicemia) 01/2019 - 08/2007
6	Hepatitis 01/2016 - 12/2008
6	Hypertension (High Blood Pressure) 03/2015 - 05/2003
5	Tuberculosis (Tuberculoses) 01/2021 - 04/2005
5	Hepatitis C 03/2015 - 01/2005
4	Liver Cirrhosis (Hepatic Cirrhosis) 07/2014 - 01/2011
4	Hypersensitivity (Allergy) 01/2011 - 09/2003
4	Coronary Disease (Coronary Heart Disease) 02/2009 - 05/2003
4	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 01/2008 - 08/2004
3	Stroke (Strokes) 08/2019 - 01/2013
3	Septic Shock (Toxic Shock Syndrome) 01/2019 - 01/2015
3	Bacterial Infections (Bacterial Infection) 01/2017 - 01/2008
3	Chronic Renal Insufficiency 01/2017 - 07/2010
3	Fibrosis (Cirrhosis) 06/2015 - 01/2014
3	Thrombocytopenia (Thrombopenia) 01/2013 - 01/2013
3	Insulin Resistance 10/2012 - 12/2007
3	Lipodystrophy 10/2012 - 05/2003
3	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 09/2010 - 07/2002
3	Leukocytosis (Pleocytosis) 04/2006 - 08/2004
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022 - 03/2016
2	Neural Tube Defects (Exencephaly) 01/2020 - 02/2019
2	Cytomegalovirus Infections (Inclusion Disease) 06/2019 - 05/2011
2	Alcoholism (Alcohol Abuse) 01/2019 - 03/2014
2	Respiratory Insufficiency (Respiratory Failure) 01/2018 - 12/2016
2	Pneumonia (Pneumonitis) 01/2018 - 09/2008
2	Viremia 02/2014 - 08/2009
2	Lung Neoplasms (Lung Cancer) 10/2013 - 11/2010
2	Anus Neoplasms (Anal Cancer) 01/2013 - 11/2010
2	Dyslipidemias (Dyslipidemia) 10/2012 - 04/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2011 - 03/2009
2	Pancreatitis 05/2008 - 01/2008

Drug/Important Bio-Agent (IBA)

26	Pharmaceutical PreparationsIBA 01/2022 - 07/2002
16	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2006
13	RNA (Ribonucleic Acid)IBA 12/2020 - 05/2003
9	Interleukin-6 (Interleukin 6)IBA 09/2020 - 06/2013
9	C-Reactive ProteinIBA 09/2020 - 07/2008
8	Protease Inhibitors (Protease Inhibitor)IBA 01/2018 - 01/2005
7	Anti-HIV Agents (AIDS Drugs)IBA 08/2019 - 02/2009
7	Reverse Transcriptase InhibitorsIBA 01/2018 - 01/2005
7	fibrin fragment D (D-dimer)IBA 01/2017 - 06/2013
7	insulin receptor-related receptor (IRR)IBA 01/2012 - 03/2005
6	ProcalcitoninIBA 03/2018 - 08/2007
6	abacavir (Ziagen)FDA Link 01/2018 - 10/2004
6	CholesterolIBA 01/2014 - 05/2003
6	Triglycerides (Triacylglycerol)IBA 09/2011 - 11/2003
5	Ritonavir (Norvir)FDA Link 01/2018 - 11/2005
5	NucleosidesIBA 01/2018 - 01/2005
5	Anti-Bacterial Agents (Antibiotics)IBA 03/2015 - 08/2004
5	Hyaluronic Acid (Hyaluronan)IBA 07/2014 - 01/2011
5	HDL CholesterolIBA 01/2014 - 12/2007
4	Antiviral Agents (Antivirals)IBA 01/2022 - 06/2015
4	Monoclonal AntibodiesIBA 01/2022 - 01/2021
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 10/2020
3	BilirubinIBA 01/2019 - 09/2011
3	Atazanavir Sulfate (Reyataz)FDA Link 01/2018 - 01/2013
3	LipidsIBA 01/2016 - 05/2003
3	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 03/2015 - 01/2012
3	Stavudine (Zerit)FDA LinkGeneric 04/2008 - 01/2008
3	Hemoglobins (Hemoglobin)IBA 01/2003 - 01/2002
2	remdesivirIBA 01/2022 - 11/2021
2	VaccinesIBA 01/2022 - 04/2021
2	AntigensIBA 01/2022 - 04/2005
2	Azithromycin (Zithromax)FDA LinkGeneric 01/2022 - 10/2020
2	bamlanivimabIBA 01/2022 - 11/2021
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2021 - 11/2009
2	CytokinesIBA 09/2020 - 07/2019
2	dolutegravirIBA 01/2020 - 02/2019
2	6-chloropenicillanic acid S-sulfoxideIBA 01/2018 - 01/2015
2	CreatinineIBA 01/2017 - 07/2010
2	Lopinavir FDA Link 01/2016 - 01/2011
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2015 - 03/2005
2	Ciprofloxacin (Cipro)FDA LinkGeneric 03/2015 - 01/2013
2	Cefuroxime (Zinacef)FDA LinkGeneric 03/2015 - 01/2013
2	Zidovudine (Retrovir)FDA LinkGeneric 07/2014 - 04/2008
2	Vitamin D FDA LinkGeneric 07/2014 - 06/2011
2	hydroxide ionIBA 07/2014 - 06/2011
2	Indicators and Reagents (Reagents)IBA 01/2013 - 01/2008
2	Didanosine (Videx)FDA LinkGeneric 04/2008 - 01/2008

Therapy/Procedure

43	Therapeutics 01/2022 - 08/2002
17	Highly Active Antiretroviral Therapy (HAART) 10/2012 - 01/2002
13	Art Therapy 01/2021 - 01/2008
4	Transplantation 12/2019 - 05/2011
4	Critical Care (Surgical Intensive Care) 01/2019 - 01/2012
2	Organ Transplantation 01/2020 - 05/2011
2	Artificial Respiration (Mechanical Ventilation) 01/2019 - 01/2018
2	Mechanical Ventilators (Ventilator) 01/2018 - 12/2016
2	Induced Hypothermia 01/2018 - 01/2015